Related Experiment Video
Updated: Feb 7, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
[Familial hypercholesterolemia: An under-diagnosed and under-treated disease. Survey of 495 physicians]
Sophie Béliard1, Jean-Pierre Rabès2, Bertrand Cariou3
1Aix-Marseille université, Inserm, Inra, C2VN, 13005 Marseille, France; AP-HM, La Conception Hospital, Department of Nutrition, Metabolic diseases, Endocrinology, 13005 Marseille, France.
Insights
Familial hypercholesterolemia (FH), a common genetic disorder causing high cholesterol, is under-diagnosed and under-treated. Improved physician education and screening are crucial for early intervention and preventing cardiovascular disease.
Area of Science:
- Cardiology
- Genetics
- Public Health
Background:
- Familial hypercholesterolemia (FH) is a prevalent genetic disorder affecting 1 in 250 individuals.
- Characterized by elevated cholesterol from birth, FH significantly increases the risk of premature cardiovascular disease (CVD).
- Despite effective management strategies, FH remains largely under-diagnosed and under-treated, leading to preventable CVD complications.
Purpose of the Study:
- To assess the current management practices for FH in France.
- To identify challenges and needs in FH diagnosis and treatment among healthcare professionals.
Main Methods:
- A survey was conducted among 495 French general practitioners (n=200) and specialists (n=295).
- The survey focused on their approaches to managing patients with FH.
Main Results:
- Physicians demonstrated a significant underestimation of cardiovascular risk in FH patients.
- High levels of therapeutic inertia were observed in managing FH.
- Practitioners expressed a clear need for enhanced information and education regarding FH.
Conclusions:
- General practitioners play a pivotal role in identifying and managing FH due to its high prevalence and associated CVD risks.
- Recent guidelines on family screening and FH care are expected to improve patient management.
- Enhanced physician education and adherence to screening protocols are vital for mitigating the impact of FH.
Introduction:
Heterozygous familial hypercholesterolemia (FH) is one of the most frequent genetic diseases with a prevalence of 1/250. It is characterized by a very high cholesterol level since birth and is often complicated by cardiovascular diseases (CV) in young patients. While early diagnosis and appropriate therapeutic management can avoid CV complications, HF is largely under-diagnosed and therefore under-treated.
Methods:
To investigate the management of HF in France, we conducted a survey with 495 general practitioners (n=200) and specialists (n=295).
Results:
The results revealed: a large underestimation of the CV risk and a high therapeutic inertia in the management of the affected patients. The practitioners reported a real need for more information about the disease.
Conclusion:
Given the high frequency of HF and the associated cardiovascular morbidity and mortality, general practitioners have a decisive role to play for the identification and the management of these patients. The recent publication of HAS recommendations on family screening procedures and care of HF patients should improve the management of this disease.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Surveys
Protein Families
Protein Families
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Gene Families
Introduction to Surveying, Plane Surveying and Geodetic Surveys